Ken Frazier will succeed Richard Clark as Merck's CEO,
Frazier, who was named Merck’s next chief executive today, is known in the pharmaceutical industry for the same fierce combination of determination and passion that freed Cochran.
When he succeeds CEO Richard Clark at the start of the new year, he will be the first African-American to lead a major U.S. drug maker, according to Marcus Oaks, publisher of Black Health Magazine. Clark, who will reach Merck’s mandatory retirement age of 65 next year, will remain chairman of the Whitehouse Station-based company.
Tweet
No comments:
Post a Comment